BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3583398)

  • 1. Reactions of nitrogen mustards with DNA.
    Hemminki K; Kallama S
    IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
    Turner PR; Denny WA; Ferguson LR
    Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
    Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
    Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the d(CGCGAATTCGCG)2 complex of the minor groove binding alkylating agent alkamin studied by mass spectrometry.
    Majid AM; Smythe G; Denny WA; Wakelin LP
    Mol Pharmacol; 2007 Apr; 71(4):1165-78. PubMed ID: 17251328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorambucil-adducts in DNA analyzed at the oligonucleotide level using HPLC-ESI MS.
    Mohamed D; Mowaka S; Thomale J; Linscheid MW
    Chem Res Toxicol; 2009 Aug; 22(8):1435-46. PubMed ID: 19621941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
    Fleer R; Brendel M
    Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
    Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
    Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and mutagenesis induced by nitrogen mustards.
    Povirk LF; Shuker DE
    Mutat Res; 1994 Dec; 318(3):205-26. PubMed ID: 7527485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
    McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
    Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
    Romero RM; Mitas M; Haworth IS
    Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.